Dosage Forms

Articles

Recipharm Inhalation Solutions is an integrated service for inhalation products.

Recipharm Launches Development and Manufacturing Service for Inhalation Products

Hovione Technology has acquired global rights to a dry powder inhaler for pulmonary drug delivery, the Papillon DPI invented by Dr. Klaus-Dieter Beller.

Hovione Technology Acquires Rights to New Blister-Based Inhaler

Janssen’s Spravato (esketamine) gains approval with restricted distribution guidelines.

FDA Approves New Treatment for Depression

Copley Scientific-a manufacturer and provider of test instrumentations for pharmaceutical dosage forms-has officially opened its newly expanded headquarters in Colwick, United Kingdom.

Copley Scientific Formally Opens Expanded Headquarters

The agency approved Insmed’s Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex (MAC) in a limited population of patients with the disease who do not respond to conventional treatment (refractory disease).


FDA Approves New Drug for Bacterial Lung Disease

Guenter Nadler, director of Business Development at Aptar Pharma, will present an insight briefing on new drug-delivery trends in treating upper and lower respiratory tract issues on Wednesday, Oct. 9, 2018 at CPhI Worldwide.

Aptar Pharma to Host Drug Delivery Insight Briefing at CPhI 2018

Emergent BioSolutions is set to acquire Adapt Pharma, a pharmaceutical company focused on addressing the opioid overdose and addiction crisis, in a deal worth up to $735 million.

Emergent to Acquire Opioid-Focused Adapt Pharma in Deal Worth $735 Million

The purchase of Novartis’ cystic fibrosis products TOBI Podhaler and TOBI solution is expected to strengthen Mylan’s global respiratory portfolio.

Mylan Buys Novartis’ CF Products for $463 Million

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Formulation characteristics must be optimized, following device selection, to achieve the desired performance for the capsule loaded in the dry powder inhaler. 

Developing Capsules for DPIs

Recipharm adds inhalation drug manufacturing capacity with the acquisition of Sanofi’s Holmes Chapel, UK site.

Inhalation Drugs